Estrella Immunopharma ESLA Q1 2026 Earnings WiderThanExpected Loss Triggers Modest Stock Gain MED Q1 2026 Earnings EPS Surprises Significantly Despite Negative Results VNCE Q1 2026 Earnings Massive EPS Beat Surprises Market Despite Revenue Gap MUSA Q1 2026 Earnings EPS Surges 415 Above Estimates Stock Slightly Declines LAUR Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher RYZ Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Stock Gains 487